Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

BICO Group AB (publ) BCCOY OTC

Other OTC • Healthcare • Medical - Devices • SE • USD

SharesGrow Score
25/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

BICO Group AB (publ) (BCCOY) is a Medical - Devices company in the Healthcare sector, currently trading at $0.59. It has a SharesGrow Score of 23/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $1.4B, +12.4%/yr average growth. Net income is $1.0B (loss), growing at -6225.1%/yr. Net profit margin is -72.7% (negative). Gross margin is 38.9% (-40.8 pp trend).

Balance sheet: total debt is $1.5B against $1.7B equity (Debt-to-Equity (D/E) ratio 0.86, moderate). Current ratio is 1.27 (adequate). Debt-to-assets is 40.7%. Total assets: $3.7B.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 48/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 33/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

BCCOY SharesGrow Score Overview

31/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 48/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 33/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BCCOY

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
48/100
BCCOY: +12.4%/yr revenue is, -6225.1%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet BCCOY: Debt-to-Equity (D/E) ratio 0.86 (moderate), Current ratio is 1.27 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
33/100
BCCOY: Gross margin is 38.9% (-40.8 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 33/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
BCCOY: Net profit margin is -72.7%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.375-0.9
Volume6K
Avg Volume (30D)420
Market Cap$161.87M
Beta (1Y)2.52
Share Statistics
EPS (TTM)-3.59
Shares Outstanding$282.3M
IPO Date2021-09-29
Employees695
CEOMaria Forss
Financial Highlights & Ratios
Revenue (TTM)$1.41B
Gross Profit$546.98M
EBITDA$-32.81M
Net Income$-1.02B
Operating Income$-236.97M
Total Cash$1.28B
Total Debt$1.51B
Net Debt$222.8M
Total Assets$3.7B
Price / Earnings (P/E)-0.2
Price / Sales (P/S)0.12
Analyst Forecast
Company Info
CountrySE
ExchangeOther OTC
CurrencyUSD
ISINUS0887641050

Price Chart

Track all markets on TradingView
BCCOY
BICO Group AB (publ) ↗  ·  Other OTC
Healthcare • Medical - Devices
0.38 52WK RANGE 0.90

People Also View

AMEUF
AMEUF
Anteris Technologies Ltd
$5.70
-35.81%
 ASAPF
ASAPF
Aurora Spine Corporation
$0.19
+3.51%
 TNON
TNON
Tenon Medical, Inc.
$0.81
-1.39%
 BRSF
BRSF
Brain Scientific Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
 RHHBF
RHHBF
Roche Holding AG
$415.00
-0.84%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message